Targeting C/EBPbeta/SCD1/C16:1 loop-driven macrophage M2 polarization by Bruceine D improves anti-PD-1 immunotherapy in colorectal cancer. Zhao L, Huang W, Li C, Wang Q, et al. Cancer Lett 2026;656:218655.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao L, Huang W, Li C, Wang Q, et al. Targeting C/EBPbeta/SCD1/C16:1 loop-driven macrophage M2 polarization by Bruceine D improves anti-PD-1 immunotherapy in colorectal cancer. Cancer Lett 2026;656:218655.
PMID: 42250753